Eukarÿs has developed the first ever artificial expression system able to synthesize in vivo autonomously messenger RNA (mRNA) and consequently the protein of interest in mammalian and other eukaryotic cells. Using the C3P3 system, we aim to revolutionize the production processes of innovative medicines by radically reducing their production costs. We offer Pharma/Biotech, CDMO and academic institutions a range of tools based on the C3P3 system for research and industrial production enabling the high-yield production in mammalian cells of innovative protein-based drugs, such as vaccines, viral vectors for gene therapy and monoclonal antibodies.
View Top Employees from Eukarÿs SASWebsite | http://www.eukarys.com |
Revenue | $405000 |
Employees | 2 (0 on RocketReach) |
Founded | 2010 |
Address | 4 Rue Pierre Fontaine, Evry Cedex, Wallis and Futuna 91058, FR |
Phone | +33 6 24 00 17 53 |
Technologies |
JavaScript,
HTML,
PHP
+5 more
(view full list)
|
Industry | Biotechnology, Business Services General, Mrna, Business Services, C3P3 technology, RNA polymerases, Capping enzymes, Genetics, Genomics, Molecular Biology, Messenger Rna |
Web Rank | 17 Million |
Keywords | Eukaris,Com |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies |
Looking for a particular Eukarÿs SAS employee's phone or email?
The Eukarÿs SAS annual revenue was $405000 in 2024.
Eukarÿs SAS is based in Evry Cedex, Wallis and Futuna.
The NAICS codes for Eukarÿs SAS are [541, 54, 54171, 541713, 5417].
The SIC codes for Eukarÿs SAS are [873, 87].